Compounds > carbidopa

carbidopa and Dysarthosis

carbidopa has been researched along with Dysarthosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Honsberger, S; Husnain, MG; Su, JS1
Altiparmak, E; Erdoğan Küçükdağli, F; Köseoğlu, HT; Öztürk, Ö; Saltoğlu, T; Sücüllü Karadağ, Y1
Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D1
Pfeiffer, RF1

Other Studies

4 other study(ies) available for carbidopa and Dysarthosis

ArticleYear
Transient parkinsonism associated with acute Legionnaires' disease.
    BMJ case reports, 2020, Jan-07, Volume: 13, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antiparkinson Agents; Carbidopa; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Dysarthria; Humans; Legionella; Legionnaires' Disease; Levodopa; Male; Parkinsonian Disorders; Respiratory Insufficiency

2020
Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients
    Turkish journal of medical sciences, 2021, 02-26, Volume: 51, Issue:1

    Topics: Abdomen, Acute; Aged; Carbidopa; Catheterization; Deglutition Disorders; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysarthria; Dyskinesias; Endoscopy; Female; Gait; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome; Turkey

2021
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
    Neurology, 2003, Jul-22, Volume: 61, Issue:2

    Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus

2003
Amantadine-induced "vocal" myoclonus.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1

    Topics: Aged; Amantadine; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Myoclonus; Neurologic Examination; Parkinson Disease; Verbal Behavior

1996